NURS 617 / NURS617 Pharmacotherapeutics Review
Exam 1 Practice Test Actual 2024/2025 with Detailed
Rationales | 100% Verified | Pass Guaranteed – A+
Graded
Section 1: Pharmacokinetics & Pharmacodynamics (12 Questions)
Q1: A drug with a high first-pass effect is primarily metabolized in which organ
before reaching systemic circulation?
A. Kidneys
B. Liver [CORRECT]
C. Lungs
D. Spleen
Correct Answer: B
Rationale: The liver is the primary site of first-pass metabolism, where orally
administered drugs are extensively metabolized by hepatic enzymes before entering
the systemic circulation, significantly reducing bioavailability.
Q2: Which pharmacokinetic parameter describes the volume of plasma from which a
drug is completely removed per unit time?
A. Bioavailability
B. Volume of distribution
C. Clearance [CORRECT]
D. Half-life
Correct Answer: C
Rationale: Clearance represents the volume of blood or plasma completely cleared
of drug per unit time and is a measure of the body's efficiency in eliminating the drug
through metabolism and excretion.
Q3: A drug has a therapeutic index of 2. Which clinical implication is most accurate?
A. The drug has a wide margin of safety.
B. The drug requires careful monitoring because the toxic dose is close to the
effective dose. [CORRECT]
,C. The drug is completely safe at any dose.
D. The drug has no toxic effects.
Correct Answer: B
Rationale: A low therapeutic index (close to 1) indicates a narrow margin of safety
where the toxic dose is near the therapeutic dose, requiring close therapeutic drug
monitoring to avoid toxicity.
Q4: Which term describes the maximum biological effect that a drug can produce,
regardless of dose?
A. Potency
B. Efficacy [CORRECT]
C. Affinity
D. Selectivity
Correct Answer: B
Rationale: Efficacy refers to the maximal response or effect a drug can produce at
receptor saturation, whereas potency describes the dose required to produce a given
effect.
Q5: A patient taking warfarin is prescribed a new medication that induces hepatic
cytochrome P450 enzymes. What is the most likely clinical outcome?
A. Increased warfarin plasma levels and increased bleeding risk
B. Decreased warfarin plasma levels and decreased anticoagulant effect [CORRECT]
C. No change in warfarin pharmacokinetics
D. Increased warfarin protein binding and toxicity
Correct Answer: B
Rationale: Enzyme induction increases the metabolic clearance of warfarin,
decreasing its plasma concentration and reducing its anticoagulant effect,
potentially leading to subtherapeutic INR and thrombotic risk.
Q6: Which route of administration produces the most rapid onset of drug action?
A. Oral
B. Subcutaneous
C. Intravenous [CORRECT]
D. Transdermal
Correct Answer: C
Rationale: Intravenous administration delivers the drug directly into the systemic
circulation, bypassing absorption barriers and producing the most rapid onset of
pharmacological effect.
, Q7: A drug that acts as a competitive antagonist at a receptor will produce which
effect on the agonist dose-response curve?
A. Decrease the maximal response
B. Shift the curve to the right without changing maximal response [CORRECT]
C. Shift the curve to the left
D. Have no effect on the curve
Correct Answer: B
Rationale: Competitive antagonists bind reversibly to the same receptor site as the
agonist, increasing the concentration of agonist required to produce a given effect
(rightward shift) while preserving the maximal response achievable.
Q8: Which factor most significantly increases the volume of distribution of a
lipophilic drug?
A. High plasma protein binding
B. Extensive distribution into adipose tissue [CORRECT]
C. High degree of ionization at physiological pH
D. Low tissue perfusion
Correct Answer: B
Rationale: Lipophilic drugs readily cross lipid membranes and distribute extensively
into adipose tissue, which increases the apparent volume of distribution beyond
plasma volume.
Q9: The time required for the plasma concentration of a drug to decrease by 50% is
defined as:
A. Steady-state concentration
B. Elimination half-life [CORRECT]
C. Onset of action
D. Duration of action
Correct Answer: B
Rationale: The elimination half-life is the time required for the plasma drug
concentration to decrease by 50% and is used to determine dosing intervals and the
time to reach steady-state concentrations.
Q10: A patient with renal impairment is prescribed a drug that is primarily eliminated
unchanged by the kidneys. Which adjustment is most appropriate?
A. Increase the dose and frequency
B. Reduce the dose or extend the dosing interval [CORRECT]
C. No adjustment is necessary
D. Switch to an intravenous formulation
Exam 1 Practice Test Actual 2024/2025 with Detailed
Rationales | 100% Verified | Pass Guaranteed – A+
Graded
Section 1: Pharmacokinetics & Pharmacodynamics (12 Questions)
Q1: A drug with a high first-pass effect is primarily metabolized in which organ
before reaching systemic circulation?
A. Kidneys
B. Liver [CORRECT]
C. Lungs
D. Spleen
Correct Answer: B
Rationale: The liver is the primary site of first-pass metabolism, where orally
administered drugs are extensively metabolized by hepatic enzymes before entering
the systemic circulation, significantly reducing bioavailability.
Q2: Which pharmacokinetic parameter describes the volume of plasma from which a
drug is completely removed per unit time?
A. Bioavailability
B. Volume of distribution
C. Clearance [CORRECT]
D. Half-life
Correct Answer: C
Rationale: Clearance represents the volume of blood or plasma completely cleared
of drug per unit time and is a measure of the body's efficiency in eliminating the drug
through metabolism and excretion.
Q3: A drug has a therapeutic index of 2. Which clinical implication is most accurate?
A. The drug has a wide margin of safety.
B. The drug requires careful monitoring because the toxic dose is close to the
effective dose. [CORRECT]
,C. The drug is completely safe at any dose.
D. The drug has no toxic effects.
Correct Answer: B
Rationale: A low therapeutic index (close to 1) indicates a narrow margin of safety
where the toxic dose is near the therapeutic dose, requiring close therapeutic drug
monitoring to avoid toxicity.
Q4: Which term describes the maximum biological effect that a drug can produce,
regardless of dose?
A. Potency
B. Efficacy [CORRECT]
C. Affinity
D. Selectivity
Correct Answer: B
Rationale: Efficacy refers to the maximal response or effect a drug can produce at
receptor saturation, whereas potency describes the dose required to produce a given
effect.
Q5: A patient taking warfarin is prescribed a new medication that induces hepatic
cytochrome P450 enzymes. What is the most likely clinical outcome?
A. Increased warfarin plasma levels and increased bleeding risk
B. Decreased warfarin plasma levels and decreased anticoagulant effect [CORRECT]
C. No change in warfarin pharmacokinetics
D. Increased warfarin protein binding and toxicity
Correct Answer: B
Rationale: Enzyme induction increases the metabolic clearance of warfarin,
decreasing its plasma concentration and reducing its anticoagulant effect,
potentially leading to subtherapeutic INR and thrombotic risk.
Q6: Which route of administration produces the most rapid onset of drug action?
A. Oral
B. Subcutaneous
C. Intravenous [CORRECT]
D. Transdermal
Correct Answer: C
Rationale: Intravenous administration delivers the drug directly into the systemic
circulation, bypassing absorption barriers and producing the most rapid onset of
pharmacological effect.
, Q7: A drug that acts as a competitive antagonist at a receptor will produce which
effect on the agonist dose-response curve?
A. Decrease the maximal response
B. Shift the curve to the right without changing maximal response [CORRECT]
C. Shift the curve to the left
D. Have no effect on the curve
Correct Answer: B
Rationale: Competitive antagonists bind reversibly to the same receptor site as the
agonist, increasing the concentration of agonist required to produce a given effect
(rightward shift) while preserving the maximal response achievable.
Q8: Which factor most significantly increases the volume of distribution of a
lipophilic drug?
A. High plasma protein binding
B. Extensive distribution into adipose tissue [CORRECT]
C. High degree of ionization at physiological pH
D. Low tissue perfusion
Correct Answer: B
Rationale: Lipophilic drugs readily cross lipid membranes and distribute extensively
into adipose tissue, which increases the apparent volume of distribution beyond
plasma volume.
Q9: The time required for the plasma concentration of a drug to decrease by 50% is
defined as:
A. Steady-state concentration
B. Elimination half-life [CORRECT]
C. Onset of action
D. Duration of action
Correct Answer: B
Rationale: The elimination half-life is the time required for the plasma drug
concentration to decrease by 50% and is used to determine dosing intervals and the
time to reach steady-state concentrations.
Q10: A patient with renal impairment is prescribed a drug that is primarily eliminated
unchanged by the kidneys. Which adjustment is most appropriate?
A. Increase the dose and frequency
B. Reduce the dose or extend the dosing interval [CORRECT]
C. No adjustment is necessary
D. Switch to an intravenous formulation
